Mignar25-MF Tablet SR

Mignar25-MF Tablet SR belongs to the class of medications called ‘antidiabetic drugs’ used to treat type 2 diabetes mellitus. Type 2 diabetes mellitus is a chronic or life-long condition in which blood sugar or glucose levels rise more than normal. It occurs when the body does not produce enough insulin (utilizes glucose to produce energy) or if produced, it cannot function properly in the body.

Mignar25-MF Tablet SR contains Miglitol and Metformin. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Miglitol works by inhibiting intestinal enzymes that break complex sugars into simple sugars like glucose. Together, Mignar25-MF Tablet SR can effectively prevent the rise in glucose levels in the body.

You should take this medicine exactly as prescribed by the doctor. The common side-effects of Mignar25-MF Tablet SR are flatulence (gas), diarrhoea, abdominal pain, feeling sick (nausea), being sick (vomiting) and loss of appetite. These side effects can be reduced if this medicine is taken with food or after a meal. However, if any of these side effects persist or get worse, inform your doctor immediately.

It is not recommended to take Mignar25-MF Tablet SR if you are allergic to any contents of it. Mignar25-MF Tablet SR is not recommended if you are having any intestinal problems such as inflammation, ulcers, blockage, hernia, liver problems, severe kidney impairment, uncontrolled diabetes, severe dehydration, severe infections, and a recent history of heart attack or heart failure. Mignar25-MF Tablet SR is not recommended for children and adolescents below 18 years, pregnant women, and breastfeeding mothers. It should be used with caution in elderly people as they may require dose adjustments. Mignar25-MF Tablet SR may interact with alcohol and worsen the condition. Mignar25-MF Tablet SR may cause hypoglycemia (low glucose levels), so avoid driving if you develop weakness, dizziness, fast heartbeat, or decrease in alertness.

Mignar25-MF Tablet SR is a combination of two drugs: Miglitol and Metformin. This combination therapy is preferred in patients with poorly controlled diabetes. It reduces blood glucose levels, especially post-prandial glucose levels (glucose levels after meals) in type 2 diabetes mellitus patients. An increase in post-prandial glucose levels can be a risk factor for diabetes complications such as tissue and organ damage. So, a decrease in glucose levels helps control diabetes, reduce this risk and improve healthy life.

Mignar25-MF Tablet SR may cause a rare and serious side effect ‘lactic acidosis’ (buildup of lactic acid in the blood), characterized by abdominal pain, muscle cramps, vomiting, severe fatigue, and difficulty breathing. It is a life-threatening condition that requires immediate medical attention. Inform your doctor if you have any severe liver or kidney problems as their normal functioning is required to eliminate excess lactic acid from the body.  Consumption of alcohol, prolonged fasting, dehydration, uncontrolled diabetes, serious infections, and liver problems increases the risk of lactic acidosis. If you have dehydration (severe loss of body fluids) due to severe vomiting, diarrhoea, exposure to heat, or fever, stop taking Mignar25-MF Tablet SR and immediately seek medical attention. Mignar25-MF Tablet SR may cause hypoglycemia (low blood sugar) and its symptoms include sweating, dizziness, palpitations (pounding heartbeat), and shivering, etc. Whenever you experience any of these symptoms, immediately consume candies or glucose biscuits rather than ordinary sugar. If your condition doesn’t improve, consult your doctor immediately.

• Beware of hypoglycemia (low blood sugar level) symptoms include sweating, dizziness, palpitations, shivering, confusion, irritability, etc. Whenever you experience these symptoms, try to eat candies or glucose biscuits and get in touch with your doctor. Make sure you carry these with you at all times, especially for long travels.
• Before undergoing examinations such as an X-ray or CT scan or undergoing surgery, inform your doctor that you are taking Mignar25-MF Tablet SR. This medicine needs to be stopped before undergoing surgery or examination.